查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946650

2026年全球眼科人工智慧辅助诊断市场报告

Ophthalmic Artificial Intelligence-Assisted Diagnosis Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工智慧辅助眼科诊断的市场规模迅速扩张，预计将从2025年的21.7亿美元成长到2026年的25.7亿美元，复合年增长率达18.5%。过去几年的成长可归因于数位影像设备的日益普及、眼科疾病率的上升、人们对早期诊断重要性的认识不断提高、人工智慧在临床试验中的应用以及视网膜影像诊断技术的进步。

预计未来几年，人工智慧辅助眼科诊断市场将快速成长，到2030年市场规模将达到50.3亿美元，复合年增长率（CAGR）为18.2%。预测期内的成长要素包括：云端人工智慧诊断平台的扩展、远距眼科医疗服务的普及、罕见眼科疾病人工智慧演算法的改进、人工智慧开发商与医疗机构的合作，以及预测性眼科护理的日益普及。预测期内的关键趋势包括：基于人工智慧的视网膜影像分析、基于深度学习的疾病检测、预测性眼科护理模型、自动化患者病历分析以及人工智慧在临床工作流程中的应用。

预计未来几年，眼科疾病发生率的不断上升将推动眼科人工智慧辅助诊断市场的扩张。眼科疾病是指影响眼睛结构或功能的疾病或异常情况，可能导致视力障碍或眼睛健康问题。长时间使用电子设备造成的萤幕时间过长，会引发长期的视力问题，例如数位眼疲劳、眼睛干涩、长时间暴露于蓝光以及眨眼频率降低，从而增加眼科疾病的盛行率。透过分析医学影像和患者数据，人工智慧辅助眼科诊断能够准确、早期地检测、分类和预测眼科疾病，从而促进及时治疗，最大限度地降低视力丧失的风险。例如，2023年8月，总部位于瑞士的联合国机构世界卫生组织（世卫组织）报告称，全球有超过22亿人患有近视或远视，其中超过10亿人的病情是可以预防或未得到治疗的。屈光不正和白内障仍然是主要原因，但只有36%的屈光不正患者和17%的白内障患者接受了有效治疗。因此，眼科疾病的上升趋势正在推动人工智慧辅助眼科诊断市场的发展。

眼科人工智慧辅助诊断市场的企业正在加速开发创新解决方案，旨在提高诊断准确性、改善患者照护并提供预测性见解。例如，眼科资料即服务即服务（OSAS）平台就是一个数位化工具，它使眼科医生、诊所和人工智慧诊断系统能够远端存取、分析和共用眼科资料（包括视网膜影像），从而提高诊断、监测和监控的品质。例如，2025年5月，拓普康医疗解决方案公司推出了IDHea，这是一个旨在简化眼科诊断流程并改善眼科疾病管治的同时，促进个人化和主动式患者照护。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球人工智慧辅助眼科诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 基于人工智慧的视网膜影像分析
    • 利用深度学习进行疾病检测
    • 预测性眼科学模型
    • 自动化病患记录分析
    • 将人工智慧融入临床工作流程

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 诊断影像中心
  • 远端医疗服务提供者
  • 研究所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球眼科人工智慧辅助诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球人工智慧辅助眼科诊断市场规模、对比及成长率分析
  • 全球人工智慧辅助眼科诊断市场表现：规模与成长，2020-2025年
  • 全球人工智慧辅助眼科诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 基于云端的，本地部署的
  • 透过技术
  • 深度学习、机器学习、电脑视觉及其他技术
  • 透过使用
  • 医院、诊所和诊断影像中心
  • 按类型细分：云端
  • 公共云端、私有云端、混合云端
  • 按类型细分：本地部署
  • 本机伺服器安装、企业资料中心安装、专用网路安装

第十章 区域与国家分析

  • 全球人工智慧辅助眼科诊断市场：按地区、绩效和预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球人工智慧辅助眼科诊断市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 人工智慧辅助眼科诊断市场：竞争格局及市场占有率（2024年）
  • 人工智慧辅助眼科诊断市场：公司评估矩阵
  • 人工智慧辅助眼科诊断市场：公司概况
    • IDx Technologies Inc.
    • Digital Diagnostics Inc.
    • AEYE Health Inc.
    • Eyenuk Inc.
    • OphtAI

第37章：其他领先和创新企业

  • Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年眼科人工智慧辅助诊断市场：提供新机会的国家
  • 2030年人工智慧辅助眼科诊断市场：蕴藏新机会的细分领域
  • 2030年人工智慧辅助眼科诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MOAIA01_G26Q1

Ophthalmic artificial intelligence-assisted diagnosis refers to the use of AI technologies to analyze eye-related medical data, such as retinal images or patient records, for the detection, diagnosis, or monitoring of eye diseases. It combines algorithms such as machine learning and deep learning with imaging and clinical data to support faster, more accurate, and automated decision-making in ophthalmology.

The primary types of ophthalmic AI-assisted diagnosis systems are cloud-based and on-premises. Cloud-based systems are hosted on remote servers and accessed via the internet. Technologies involved include deep learning, machine learning, natural language processing (NLP), computer vision, and others. These systems are applied in settings such as hospitals, clinics, and imaging centers.

Tariffs have influenced the ophthalmic ai-assisted diagnosis market by increasing the import costs of imaging devices, ai-enabled software, and high-resolution cameras. This has particularly affected hospitals, clinics, and imaging centers in Asia-Pacific and Europe. Segments relying on imported retinal cameras and ai software are most impacted. However, tariffs have encouraged local software development and domestic production of imaging systems, which may improve supply chain resilience and reduce long-term costs.

The ophthalmic artificial intelligence-assisted diagnosis market research report is one of a series of new reports from The Business Research Company that provides ophthalmic artificial intelligence-assisted diagnosis market statistics, including ophthalmic artificial intelligence-assisted diagnosis industry global market size, regional shares, competitors with a ophthalmic artificial intelligence-assisted diagnosis market share, detailed ophthalmic artificial intelligence-assisted diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic artificial intelligence-assisted diagnosis industry. This ophthalmic artificial intelligence-assisted diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ophthalmic artificial intelligence-assisted diagnosis market size has grown rapidly in recent years. It will grow from $2.17 billion in 2025 to $2.57 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to increasing adoption of digital imaging devices, rising prevalence of eye diseases, awareness of early diagnosis, integration of ai in clinical trials, advancements in retinal imaging technology.

The ophthalmic artificial intelligence-assisted diagnosis market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to growth of cloud-based ai diagnostic platforms, expansion of tele-ophthalmology services, improved ai algorithms for rare eye disorders, partnerships between ai developers and hospitals, increased adoption of predictive ophthalmology. Major trends in the forecast period include AI-based retinal imaging analysis, deep learning-powered disease detection, predictive ophthalmology models, automated patient record analysis, integration of ai with clinical workflows.

The increasing incidence of eye disorders is anticipated to drive the expansion of the ophthalmic artificial intelligence-assisted diagnosis market in the coming years. Eye disorders are medical conditions or abnormalities that affect the structure or function of the eye, potentially leading to impaired vision or compromised eye health. The prevalence of eye disorders is growing due to prolonged screen time from digital device usage, which can result in digital eye strain, dryness, and long-term vision problems from extended blue light exposure and reduced blinking frequency. Ophthalmic artificial intelligence-assisted diagnosis aids by analyzing medical images and patient data to detect, classify, and predict eye disorders with accuracy and at an early stage, facilitating timely treatment and minimizing the risk of vision loss. For example, in August 2023, the World Health Organization (WHO), a Switzerland-based United Nations agency, reported that over 2.2 billion people globally live with near or distance vision impairment-more than 1 billion of whom have preventable or untreated conditions. Refractive errors and cataracts remain the primary causes, while access to effective interventions reaches only 36% of individuals with refractive error-related impairment and just 17% of those with cataract-related impairment. Consequently, the growing prevalence of eye disorders is fueling the development of the ophthalmic artificial intelligence-assisted diagnosis market.

Companies in the ophthalmic AI-assisted diagnosis market are increasingly developing innovative solutions to improve diagnostic accuracy, enhance patient care, and provide predictive insights. One such solution is the ocular data-as-a-service platform, a digital tool that allows ophthalmologists, clinics, and AI diagnostic systems to remotely access, analyze, and share ocular data such as retinal images. This improves diagnosis, monitoring, and research. For instance, in May 2025, Topcon Healthcare Solutions Inc. introduced IDHea, a cloud-based platform designed to streamline ophthalmic diagnostics and improve patient outcomes. By offering fast and secure access to real-world and clinical ocular datasets, IDHea accelerates AI and digital health innovation. It helps researchers generate AI-driven insights to advance both eye and systemic disease care. Built on principles of fast access, safety, and transparency, IDHea facilitates personalized and proactive patient care while ensuring privacy and governance.

In May 2025, Topcon Healthcare Inc. strengthened its AI-driven ophthalmic diagnostic capabilities by acquiring RetInSight GmbH. This acquisition supports the company's objective of advancing global eye care through intelligent diagnostic solutions. RetInSight GmbH, an Austrian medtech company, specializes in AI-assisted ophthalmic diagnostics. With this acquisition, Topcon Healthcare enhances its ability to deliver high-quality eye care, reduce costs, and improve clinical outcomes through innovations in retinal imaging.

Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are IDx Technologies Inc., Digital Diagnostics Inc., AEYE Health Inc., Eyenuk Inc., OphtAI, Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd., Neurodynamics Solutions Inc.

North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The ophthalmic artificial intelligence-assisted diagnosis market includes revenues earned by entities by providing services such as technical support and maintenance, clinical trial support, training and consultation, data management, and annotation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ophthalmic artificial intelligence-assisted diagnosis market also includes sales of wearable eye-tracking devices, retinal scanners, AI-enabled slit-lamp imaging devices, and portable artificial intelligence ophthalmic diagnostic kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ophthalmic artificial intelligence-assisted diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ophthalmic artificial intelligence-assisted diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic artificial intelligence-assisted diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Cloud-Based; On-Premises
  • 2) By Technology: Deep Learning; Machine Learning; Computer Vision; Other Technologies
  • 3) By Application: Hospital; Clinic; Imaging Centre
  • Subsegments:
  • 1) By Cloud-Based: Public Cloud; Private Cloud; Hybrid Cloud
  • 2) By On-Premises: Local Server Deployment; Enterprise Data Center Deployment; Private Network Deployment
  • Companies Mentioned: IDx Technologies Inc.; Digital Diagnostics Inc.; AEYE Health Inc.; Eyenuk Inc.; OphtAI; Oivi Tech Private Limited; Altris Inc.; JuneBrain Inc.; Mediwhale Inc.; MONA.health BV; Remidio Innovative Solutions Pvt. Ltd.; Retinalyze System A/S; Retmarker; RetinaRisk; Ikerian AG; VoxelCloud Inc.; Visulytix Ltd.; Aiforia Technologies Plc; DeepTek Inc.; EyRIS Pte Ltd.; Neurodynamics Solutions Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Ai-Based Retinal Imaging Analysis
    • 4.2.2 Deep Learning-Powered Disease Detection
    • 4.2.3 Predictive Ophthalmology Models
    • 4.2.4 Automated Patient Record Analysis
    • 4.2.5 Integration Of Ai With Clinical Workflows

5. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Imaging Centres
  • 5.4 Telemedicine Providers
  • 5.5 Research Institutes

6. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Segmentation

  • 9.1. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cloud-Based, On-Premises
  • 9.2. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Deep Learning, Machine Learning, Computer Vision, Other Technologies
  • 9.3. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Clinic, Imaging Centre
  • 9.4. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Sub-Segmentation Of Cloud-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Public Cloud, Private Cloud, Hybrid Cloud
  • 9.5. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Sub-Segmentation Of On-Premises, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Local Server Deployment, Enterprise Data Center Deployment, Private Network Deployment

10. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Regional And Country Analysis

  • 10.1. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 11.1. Asia-Pacific Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 12.1. China Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 13.1. India Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 14.1. Japan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 15.1. Australia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 16.1. Indonesia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 17.1. South Korea Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 18.1. Taiwan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 19.1. South East Asia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 20.1. Western Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 21.1. UK Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 22.1. Germany Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 23.1. France Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 24.1. Italy Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 25.1. Spain Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 26.1. Eastern Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 27.1. Russia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 28.1. North America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 29.1. USA Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 30.1. Canada Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 31.1. South America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 32.1. Brazil Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 33.1. Middle East Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 34.1. Africa Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Regulatory and Investment Landscape

36. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Competitive Landscape And Company Profiles

  • 36.1. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Company Profiles
    • 36.3.1. IDx Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Digital Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. AEYE Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Eyenuk Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. OphtAI Overview, Products and Services, Strategy and Financial Analysis

37. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Other Major And Innovative Companies

  • Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd.

38. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

40. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market High Potential Countries, Segments and Strategies

  • 40.1 Ophthalmic Artificial Intelligence-Assisted Diagnosis Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Ophthalmic Artificial Intelligence-Assisted Diagnosis Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Ophthalmic Artificial Intelligence-Assisted Diagnosis Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer